News tagged with 'GM'

Drugmaker, Pfizer, is now disclosing what it pays to doctors in speaking fees and consulting in a downloadable, searchable database, an early jump on the Physician Payments Sunshine provision.

Four of five new drugs are awaiting approval by the FDA and hope to become blockbusters for their pharmaceutical drugmakers and inject new life into profits.

Bayer must pay two farmer $2 million for contaminating their fields with genetically engineered (GE) rice, which contains a novel protein that resists Bayer's herbicide sprayed after the corn grows. The company profits on both ends, but farmers lost their ability to export to countries that ban GE foods.

A group of people who were injured or lost loved ones due to unsafe and defective Chrysler vehicles rallied together and held a protest outside the company's Auburn Hills headquarters yesterday.

Victims of defective GM and Chrysler vehicles will have no remedy through the courts under the new company, owned by Fiat.  The deal was orchestrated to help the company emerge from bankruptcy through the U.S. Treasury Department and involves 40 million vehicles currently on the road and thousands of pending claims.  

Opposing forces, from citizens injured by drugs or their survivors, to lobbyists from the largest drug companies are expected in Lansing, Michigan Wednesday, as the state considers repealing its drugmaker immunity law - the only one in the nation put in place by former Gov. John Engler. 

Gulf War syndrome, dismissed by many as a psychosomatic disorder, is a very real illness that still afflicts 25 percent of the 700,000 U.S. veterans who took part in the 1991 Gulf War, finds a new report by a federal panel of scientific experts.

New findings from the US Preventive Services Task Force suggest routine colorectal cancer screenings can be stopped in patients over the age of 75. The results are based on patients who began screenings at age 50 and have had consistently negative screenings up to the age of 75.

FDA Approves Alzheimer’s Patch The FDA has approved the first transdermal patch for the treatment of Alzheimer’s dementia. The drug rivastigmine, known by the prescription brand Exelon , has been available since 1997 in capsule and in tablet form, but only now has the drug been approved by the FDA as